• Centers and Programs
  • Alzheimer's Disease Center
  • Center for Brain Injury and Repair
  • Center for Cognitive Neuroscience
  • Center for Frontotemporal Degeneration and Related Disorders
  • Center for Functional Neuroimaging
  • Center for Sleep and Respiratory Biology
  • Mahoney Institute of Neurological Sciences
  • Multiple Sclerosis Program
  • Neuro-Ophthalmology Program
  • Smell and Taste Center
  • Vision Research Center
• Clinical Trials
  • Cognitive Neurology (Memory Disorders)
  • Epilepsy
  • Herpes Simplex Encephalitis
  • Multiple Sclerosis
  • Neuromuscular
  • Neuro-Oncology
  • Parkinson's Disease / Movement Disorders
  • Acute Stroke
  • Stroke Prevention

   

Primary Study Objective
To determine changes in SPECT scan results when Parkinson's patients are started on dopamine agonists vs. levodopa

Study Population
Patients who are newly diagnosed with Parkinson's disease adn are untreated

Principal Investigators
Andrew Siderowf, MD

Contact Person
Suzanne Reichwein BASW 
Phone (215) 829-7273